Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0109987" target="_blank" >RIV/00843989:_____/23:E0109987 - isvavai.cz</a>
Alternative codes found
RIV/61988987:17110/23:A2402JKN RIV/00098892:_____/23:10158094
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/10.1002/ajh.26602" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/ajh.26602</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ajh.26602" target="_blank" >10.1002/ajh.26602</a>
Alternative languages
Result language
angličtina
Original language name
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis
Original language description
Patients with multiple myeloma (MM) often relapse or become refractory to successive lines of therapy (LOT), warranting more effective treatments. Novel treatments have improved outcomes; however, MM is associated with a significant patient burden. Patients who are refractory to immunomodulatory drugs and proteasome inhibitors (PIs) have poor prognosis. Many patients with MM are exposed to lenalidomide or bortezomib in early LOT; those refractory to these agents are challenging to treat and represent a high unmet medical need.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
American journal of hematology
ISSN
0361-8609
e-ISSN
1096-8652
Volume of the periodical
98
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
1
Pages from-to
e15-e19
UT code for WoS article
000805749800001
EID of the result in the Scopus database
2-s2.0-85131155211